Mills Pharmaceuticals Overview
Mills Pharmaceuticals General Information
Provider of bio pharmaceutical research and development services. The company develops GALE-401, a controlled release formulation of anagrelide used for the treatment of essential thrombocythemia.
Want to dig into this profile?
We’ll help you find what you need
Mills Pharmaceuticals Valuation & Funding
This information is available in the PitchBook Platform. To explore Mills Pharmaceuticals‘s full profile, request access.
Request a free trial